News
China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH ...
Roche's PiaSky is the first therapy for rare blood disorder PNH that can be given by monthly subcutaneous injection in the EU.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback